James Thomson News
Most Popular James Thomson Story
Stem cell spin-offs merge with $18M in new VC cash
Renowned University of Wisconsin stem cell scientist James Thomson is merging three university spin-off companies into a single entity charged with commercializing stem cell technology in drug... Read more...
Latest Headlines
- November 25, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
